Influx Healthtech (INFLUX) Stock Overview
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
INFLUX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Influx Healthtech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹226.35 |
| 52 Week High | ₹249.00 |
| 52 Week Low | ₹120.00 |
| Beta | 0 |
| 1 Month Change | 14.29% |
| 3 Month Change | 20.30% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 79.36% |
Recent News & Updates
Shareholder Returns
| INFLUX | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -4.5% | 0.5% | -0.3% |
| 1Y | n/a | -0.9% | -2.3% |
Return vs Industry: Insufficient data to determine how INFLUX performed against the Indian Life Sciences industry.
Return vs Market: Insufficient data to determine how INFLUX performed against the Indian Market.
Price Volatility
| INFLUX volatility | |
|---|---|
| INFLUX Average Weekly Movement | 7.2% |
| Life Sciences Industry Average Movement | 5.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.6% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: INFLUX's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine INFLUX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 163 | Munir Abdul Chandniwala | influxhealthtech.com |
Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleaning products. It also provides dietary and nutritional supplements in the form of tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, candies, gym/sports supplements, effervescent tablets, and liquid fill capsules; and cosmetics products, such as skin, body care, hair care, beard care, and face mask products, as well as soaps for men and women.
Influx Healthtech Limited Fundamentals Summary
| INFLUX fundamental statistics | |
|---|---|
| Market cap | ₹5.24b |
| Earnings (TTM) | ₹177.56m |
| Revenue (TTM) | ₹1.24b |
Is INFLUX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INFLUX income statement (TTM) | |
|---|---|
| Revenue | ₹1.24b |
| Cost of Revenue | ₹717.66m |
| Gross Profit | ₹517.93m |
| Other Expenses | ₹340.37m |
| Earnings | ₹177.56m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.67 |
| Gross Margin | 41.92% |
| Net Profit Margin | 14.37% |
| Debt/Equity Ratio | 0% |
How did INFLUX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/13 04:22 |
| End of Day Share Price | 2025/12/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Influx Healthtech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.